Author: Site Editor Publish Time: 08-10-2026 Origin: Site
The popularity of polynucleotides for face treatments has grown rapidly in recent years. Real-world application feedback has been positive, and before-and-after photos often show visible changes in skin texture, firmness, and radiance. This visible skin improvement is one reason PN treatments have gained wider use in aesthetic practice.Here, we break down the key points of polynucleotides for face and their applications.
Polynucleotides (PN) are purified DNA-derived polymers, commonly extracted from salmon or trout. Their biological activity is closely related to tissue repair and skin regeneration. PN can support fibroblast activity, extracellular matrix remodeling, and tissue repair.
For this reason, polynucleotide treatment for the face is particularly suitable for patients with early signs of aging, reduced skin elasticity, more visible fine lines, or generally poor skin quality.
PN for face treatments are commonly used to address the following concerns:
Overall skin quality improvement: Improve rough texture, visible pores, uneven skin tone, and reduced elasticity.
Periorbital rejuvenation: For thin, crepey skin and fine lines around the eyes, specially formulated PN products can be used for targeted treatment.
Scar repair: This includes atrophic acne scars and post-surgical scars. The anti-inflammatory properties of PN may have a positive effect on scar tissue remodeling.
Different areas of the face have different skin characteristics. The skin around the eyes is thin and delicate, while the cheeks, forehead, and other facial areas differ in tissue thickness and treatment needs. Therefore, using the same PN product and treatment protocol across the entire face may not always be the most suitable approach.
For clinics, an area-based treatment strategy helps match the PN formulation more precisely to the specific needs of each facial area.
For example, PNPure™ NeoSkin contains 25 mg/mL of high-concentration PN and is designed for skin with overall signs of aging, reduced elasticity, visible photodamage, and a need for comprehensive rejuvenation.
PNPure™ NeoEye contains 10 mg/mL of PN and is specifically designed for the characteristics of the periorbital area. It can be used to address concerns such as fine lines and thinning skin around the eyes.
PNPure™ NeoBalance combines 10 mg/mL of PN with 10 mg/mL of hyaluronic acid (HA). It can be used for targeted hydration and moisture management in areas that are prone to dryness, dehydration, or rough skin texture, such as the sides of the nose, perioral area, and chin.
In summary, clinics should select the appropriate product combination based on the treatment area, skin condition, and specific treatment goals, rather than using the same formulation across all facial areas.
Next, using PNPure™ as an example, let’s look at how treatment protocols involving facial polynucleotides are designed.
Injection depth:
For facial injections, PN is generally administered into the superficial to mid dermis, using a small volume at each injection point.
Inital treatment course:
PN treatment is usually performed as a course rather than a single procedure. A common clinical protocol involves 2–3 treatments spaced approximately 3–4 weeks apart.
Maintenance treatment:
After completing the initial treatment course, maintenance treatment may be considered every 6–12 months, depending on the patient's response and treatment goals.
It is important to note that the exact schedule should be adjusted according to the product used, treatment area, skin condition, and the practitioner's assessment.
The adverse reactions to PN are generally mild. Within 24 hours after injection, mild redness, a burning sensation, or small pinpoint hematomas may occur, and these usually resolve on their own within one week.
Patients are advised to avoid direct sun exposure and irritating skincare products for 48 hours after treatment. Local cold compresses can be used to relieve discomfort, and high-temperature environments such as saunas and strenuous exercise should be avoided for one week after injection.
It is also important to note that the effects of PN are not immediate. The treatment follows a “repair first, results later” process. Patients usually begin to notice more visible changes in the face after completing 2–3 treatment sessions.
The application logic of Polynucleotides for Face can be summarized as: “regeneration rather than filling, area-based treatment rather than a one-size-fits-all approach.”
For aesthetic clinics, choosing the right product system, especially an area-specific product line such as PNPure™, matching it with a standardized injection protocol, and managing patient expectations are three key steps. When these are properly addressed, they can help support better treatment outcomes.
